The Role of the Pediatric Intensivist in the Coronavirus Disease 2019 Pandemic
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Critical Care Medicine"
DOI: 10.1097/pcc.0000000000002433
Abstract: 928 www.pccmjournal.org October 2020 • Volume 21 • Number 10 response in premature infants with mild-to-moderate respiratory distress. In this regard, we agree with the comment by Madney et al (1) that the experimental period… read more here.
Keywords: role; pediatric intensivist; intensivist coronavirus; treatment ... See more keywords
From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy
Sign Up to like & getrecommendations! Published in 2019 at "Respiratory Research"
DOI: 10.1186/s12931-019-1096-9
Abstract: BackgroundNon-invasive delivery of nebulized surfactant has been a neonatology long-pursued goal. Nevertheless, the clinical efficacy of nebulized surfactant remains inconclusive, in part, due to the great technical challenges of depositing nebulized drugs in the lungs… read more here.
Keywords: poractant alfa; delivery; nebulized surfactant; delivery strategy ... See more keywords
Budesonide and Poractant Alfa prevent bronchopulmonary dysplasia via triggering SIRT1 signaling pathway.
Sign Up to like & getrecommendations! Published in 2019 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_201912_19811
Abstract: OBJECTIVE This study aimed to evaluate effect of budesonide combining Poractant Alfa on preventing bronchopulmonary dysplasia (BPD). PATIENTS AND METHODS A total of 120 preterm infants were involved. pH value, partial pressure of oxygen (PO2),… read more here.
Keywords: sirt1; bronchopulmonary dysplasia; poractant alfa; group ... See more keywords
In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2017.00186
Abstract: Background Poractant alfa (Curosurf®) and Bovactant (Alveofact®) are two animal-derived pulmonary surfactants preparations approved for the treatment of neonatal respiratory distress syndrome (nRDS). They differ in their source, composition, pharmaceutical form, and clinical dose. How… read more here.
Keywords: poractant alfa; alfa; respiratory distress; preterm lambs ... See more keywords